High brain serotonin levels in migraine between attacks: A 5-HT4-receptor binding PET study
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Standard
High brain serotonin levels in migraine between attacks : A 5-HT4-receptor binding PET study. / Deen, Marie; Hansen, Hanne D.; Hougaard, Anders; Eiberg, Hans; Lehel, Szabolcs; Ashina, Messoud; Knudsen, Gitte M.
In: Cephalalgia, Vol. 37, No. 1_suppl, PO-01-023, 2017, p. 66-66.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - ABST
T1 - High brain serotonin levels in migraine between attacks
T2 - A 5-HT4-receptor binding PET study
AU - Deen, Marie
AU - Hansen, Hanne D.
AU - Hougaard, Anders
AU - Eiberg, Hans
AU - Lehel, Szabolcs
AU - Ashina, Messoud
AU - Knudsen, Gitte M.
PY - 2017
Y1 - 2017
N2 - ObjectivesTo investigate brain 5-HT4-receptor binding with positron emission tomography (PET) as a proxy of serotonin (5-hydroxytryptamine, 5-HT) levels in migraine patients between attacks.MethodsBrain 5-HT4-receptor binding, assessed with PET imaging of the specific 5-HT4-receptor radioligand, [11C]SB207145, is inversely related to long-term changes in brain 5-HT-levels. Eighteen migraine patients without aura (≥48 hours migraine free) and 16 age- and sex-matched controls underwent PET-scanning after injection of [11C]SB207145. Patients who reported a migraine attack ≤48 hours after the scan were excluded. The mean neocortical [11C]SB207145 binding potential (BPND) was calculated in a blinded manner.ResultsFifteen patients (age 29.6 ± 10.2 years, 2 men) and 16 controls (28.9 ± 10.2 years, 3 men) completed the study. Migraine patients had significantly lower neocortical 5-HT4-receptor binding than controls (0.62 ± 0.09 vs. 0.68 ± 0.05, p = 0.024). We found no associations between 5-HT4-receptor binding and clinical migraine characteristics.ConclusionMigraine patients have lower neocortical 5-HT4-receptor binding than controls, which may reflect a chronic or at least episodically high brain 5-HT-level. Our finding is in apparent contrast with the longstanding hypothesis of migraine being a syndrome of chronic low brain 5-HT-levels. We were unable to demonstrate any associations with attack frequency or years with migraine. This suggests that high brain 5-HT-levels may be a trait of the migraine brain rather than a consequence of migraine attacks.
AB - ObjectivesTo investigate brain 5-HT4-receptor binding with positron emission tomography (PET) as a proxy of serotonin (5-hydroxytryptamine, 5-HT) levels in migraine patients between attacks.MethodsBrain 5-HT4-receptor binding, assessed with PET imaging of the specific 5-HT4-receptor radioligand, [11C]SB207145, is inversely related to long-term changes in brain 5-HT-levels. Eighteen migraine patients without aura (≥48 hours migraine free) and 16 age- and sex-matched controls underwent PET-scanning after injection of [11C]SB207145. Patients who reported a migraine attack ≤48 hours after the scan were excluded. The mean neocortical [11C]SB207145 binding potential (BPND) was calculated in a blinded manner.ResultsFifteen patients (age 29.6 ± 10.2 years, 2 men) and 16 controls (28.9 ± 10.2 years, 3 men) completed the study. Migraine patients had significantly lower neocortical 5-HT4-receptor binding than controls (0.62 ± 0.09 vs. 0.68 ± 0.05, p = 0.024). We found no associations between 5-HT4-receptor binding and clinical migraine characteristics.ConclusionMigraine patients have lower neocortical 5-HT4-receptor binding than controls, which may reflect a chronic or at least episodically high brain 5-HT-level. Our finding is in apparent contrast with the longstanding hypothesis of migraine being a syndrome of chronic low brain 5-HT-levels. We were unable to demonstrate any associations with attack frequency or years with migraine. This suggests that high brain 5-HT-levels may be a trait of the migraine brain rather than a consequence of migraine attacks.
U2 - 10.1177/0333102417719573
DO - 10.1177/0333102417719573
M3 - Conference abstract in journal
C2 - 28880581
VL - 37
SP - 66
EP - 66
JO - Cephalalgia
JF - Cephalalgia
SN - 0800-1952
IS - 1_suppl
M1 - PO-01-023
ER -
ID: 183833640